Dr. Johanna Scholz, Autor auf Euroimmun Blog https://www.euroimmunblog.com/author/johannafraune/ Forschung, Wissenschaft und Diagnostik Tue, 12 May 2026 09:18:52 +0000 en-US hourly 1 https://www.euroimmunblog.com/wp-content/uploads/2025/08/cropped-favicon_256x256-32x32.png Dr. Johanna Scholz, Autor auf Euroimmun Blog https://www.euroimmunblog.com/author/johannafraune/ 32 32 Euroimmun and IDS: Working together for the IDS i20 https://www.euroimmunblog.com/euroimmun-and-ids-for-the-ids-i20/ https://www.euroimmunblog.com/euroimmun-and-ids-for-the-ids-i20/#respond Thu, 23 Apr 2026 11:55:09 +0000 https://www.euroimmunblog.de/?p=9311 #bettertogether Last spring, IDS and Euroimmun launched the new random access instrument IDS i20. This new automation solution followed the random access instruments IDS-i10 and IDS-iSYS already established in the market. The device was developed based on IDS’ 50 years of expertise in laboratory automation – always focusing on maximum convenience for the users and reliability. For […]

Der Beitrag Euroimmun and IDS: Working together for the IDS i20 erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/euroimmun-and-ids-for-the-ids-i20/feed/ 0 New e-mail addresses for all Euroimmun employees https://www.euroimmunblog.com/new-e-mail-addresses-euroimmun/ https://www.euroimmunblog.com/new-e-mail-addresses-euroimmun/#respond Tue, 14 Apr 2026 12:35:36 +0000 https://www.euroimmunblog.de/?p=9265 Following the successful launch of our new design last summer, another change at Euroimmun and IDS takes place, which makes our affiliation to Revvity, Inc. more visible. As part of our strategic development, we are consolidating the technical systems of our three companies. This will enable us to provide an even better service thanks to […]

Der Beitrag New e-mail addresses for all Euroimmun employees erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/new-e-mail-addresses-euroimmun/feed/ 0 What you know and trust – now with a new shine https://www.euroimmunblog.com/euroimmun-rebranding/ https://www.euroimmunblog.com/euroimmun-rebranding/#respond Tue, 29 Jul 2025 13:51:05 +0000 https://www.euroimmunblog.de/?p=8899 Our new design is here!  Clearer, more modern, more international.   With our new design and visual language we have achieved a strong visual alignment with the corporate identity of Revvity, Inc. At the same time, we harmonized the visual appearance of the Euroimmun and IDS brands creating a new modernized look which visually reflects our shared identity and growing collaboration.  But what really counts remains the same: our […]

Der Beitrag What you know and trust – now with a new shine erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/euroimmun-rebranding/feed/ 0 What you know and trust – soon with a new shine https://www.euroimmunblog.com/what-you-know-and-trust-soon-with-a-new-shine/ https://www.euroimmunblog.com/what-you-know-and-trust-soon-with-a-new-shine/#respond Tue, 08 Jul 2025 09:30:07 +0000 https://www.euroimmunblog.de/?p=8773 Euroimmun is modernizing its brand appearance Our company has undergone significant developments in recent years. This will now also be reflected in our visual appearance. At the ADLM in Chicago (July 27–31, 2025), we will show you our new, modernized look for the first time, underlining our innovative power and our international orientation. But, of […]

Der Beitrag What you know and trust – soon with a new shine erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/what-you-know-and-trust-soon-with-a-new-shine/feed/ 0 Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay https://www.euroimmunblog.com/revvitys-euroimmun-receives-ce-mark-for-novel-measles-antibody-detection-assay/ https://www.euroimmunblog.com/revvitys-euroimmun-receives-ce-mark-for-novel-measles-antibody-detection-assay/#respond Mon, 03 Mar 2025 19:17:05 +0000 https://www.euroimmunblog.de/?p=8531 Press release, March 3rd 2025 Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus. EUROIMMUN’s Anti-Measles Virus ELISA 2.0 (IgG) is the first of several assays in development expanding EUROIMMUN’s […]

Der Beitrag Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/revvitys-euroimmun-receives-ce-mark-for-novel-measles-antibody-detection-assay/feed/ 0